Home » Topics » BioWorld Science

BioWorld Science
RSS

Oncorus enrolling in first-in-human trial of oncolytic immunotherapy ONCR-177

April 23, 2020

FDA approves Trodelvy for previously treated metastatic TNBC

April 23, 2020

New HBV HBeAg and HBsAg secretion inhibitors presented by Roche

April 23, 2020

Medshine Discovery identifies AOC3 inhibitors

April 23, 2020

iTeos Therapeutics presents adenosine A2A receptor antagonists

April 23, 2020

Antabio SAS divulges Pseudomonas aeruginosa elastase inhibitors

April 23, 2020

Takeda Pharmaceutical discloses new GIPR agonists

April 23, 2020

Alpha Cognition signs up CRO to support development of Alpha-1062 for Alzheimer's

April 23, 2020

GRP78 does not predict bortezomib response in patients with multiple myeloma

April 23, 2020

Polymer-linked rotigotine shows promise in patients with PD

April 23, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...